Among these genes, Per2 is reported to have tumor suppressor properties, but little is known about the correlation between Per2 and HIF, which is the main target of renal cell carcinoma (RCC) therapy. The gene discussed is PER2; the disease is hereditary clear cell renal cell carcinoma.